Literature DB >> 22711941

Anti-AIDS agents 88. Anti-HIV conjugates of betulin and betulinic acid with AZT prepared via click chemistry.

Ibrahim D Bori1, Hsin-Yi Hung, Keduo Qian, Chin-Ho Chen, Susan L Morris-Natschke, Kuo-Hsiung Lee.   

Abstract

In the present study, a new strategy to link AZT with betulin/betulinic acid (BA) by click chemistry was designed and achieved. This conjugation via a triazole linkage offers a new direction for modification of anti-HIV triterpenes. Click chemistry provides an easy and productive way for linking two molecules, even when one of them is a large natural product. Among the newly synthesized conjugates, compounds 15 and 16 showed potent anti-HIV activity with EC(50) values of 0.067 and 0.10 µM, respectively, which are comparable to that of AZT (EC(50): 0.10 µM) in the same assay.

Entities:  

Year:  2012        PMID: 22711941      PMCID: PMC3375835          DOI: 10.1016/j.tetlet.2012.02.022

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  9 in total

1.  Click Chemistry: Diverse Chemical Function from a Few Good Reactions.

Authors:  Hartmuth C. Kolb; M. G. Finn; K. Barry Sharpless
Journal:  Angew Chem Int Ed Engl       Date:  2001-06-01       Impact factor: 15.336

2.  Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents.

Authors:  Y Kashiwada; F Hashimoto; L M Cosentino; C H Chen; P E Garrett; K H Lee
Journal:  J Med Chem       Date:  1996-03-01       Impact factor: 7.446

3.  Conjugates of betulin derivatives with AZT as potent anti-HIV agents.

Authors:  Juan Xiong; Yoshiki Kashiwada; Chin-Ho Chen; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee; Yoshihisa Takaishi
Journal:  Bioorg Med Chem       Date:  2010-07-07       Impact factor: 3.641

4.  Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation.

Authors:  T Kanamoto; Y Kashiwada; K Kanbara; K Gotoh; M Yoshimori; T Goto; K Sano; H Nakashima
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 5.  Pharmacological properties of the ubiquitous natural product betulin.

Authors:  Sami Alakurtti; Taru Mäkelä; Salme Koskimies; Jari Yli-Kauhaluoma
Journal:  Eur J Pharm Sci       Date:  2006-04-29       Impact factor: 4.384

6.  Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers.

Authors:  David E Martin; Robert Blum; John Wilton; Judy Doto; Hal Galbraith; Gina L Burgess; Philip C Smith; Charles Ballow
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

Authors:  F Li; R Goila-Gaur; K Salzwedel; N R Kilgore; M Reddick; C Matallana; A Castillo; D Zoumplis; D E Martin; J M Orenstein; G P Allaway; E O Freed; C T Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

8.  Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers.

Authors:  David E Martin; Robert Blum; Judy Doto; Hal Galbraith; Charles Ballow
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection.

Authors:  Patrick F Smith; Abayomi Ogundele; Alan Forrest; John Wilton; Karl Salzwedel; Judy Doto; Graham P Allaway; David E Martin
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

  9 in total
  8 in total

Review 1.  Recent advances in natural anti-HIV triterpenoids and analogs.

Authors:  Hai-Feng Wu; Susan L Morris-Natschke; Xu-Dong Xu; Mei-Hua Yang; Yung-Yi Cheng; Shi-Shan Yu; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-14       Impact factor: 12.944

2.  Preparation of azidoaryl- and azidoalkyloxazoles for click chemistry.

Authors:  Catherine M Loner; Frederick A Luzzio; Donald R Demuth
Journal:  Tetrahedron Lett       Date:  2012-10-17       Impact factor: 2.415

Review 3.  Structure and Anti-HIV Activity of Betulinic Acid Analogues.

Authors:  Qiu-Xia Huang; Hong-Fei Chen; Xing-Rui Luo; Yin-Xiang Zhang; Xu Yao; Xing Zheng
Journal:  Curr Med Sci       Date:  2018-06-22

Review 4.  Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential.

Authors:  Gabriela Nistor; Cristina Trandafirescu; Alexandra Prodea; Andreea Milan; Andreea Cristea; Roxana Ghiulai; Roxana Racoviceanu; Alexandra Mioc; Marius Mioc; Viviana Ivan; Codruța Șoica
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

5.  Antineoplastic agents. 595. Structural modifications of betulin and the X-ray crystal structure of an unusual betulin amine dimer.

Authors:  George R Pettit; Noeleen Melody; Frank Hempenstall; Jean-Charles Chapuis; Thomas L Groy; Lee Williams
Journal:  J Nat Prod       Date:  2014-04-02       Impact factor: 4.050

6.  Novel Triazole Hybrids of Betulin: Synthesis and Biological Activity Profile.

Authors:  Ewa Bębenek; Maria Jastrzębska; Monika Kadela-Tomanek; Elwira Chrobak; Beata Orzechowska; Katarzyna Zwolińska; Małgorzata Latocha; Anna Mertas; Zenon Czuba; Stanisław Boryczka
Journal:  Molecules       Date:  2017-11-01       Impact factor: 4.411

7.  Synthesis, structure and cytotoxic activity of new acetylenic derivatives of betulin.

Authors:  Stanisław Boryczka; Ewa Bębenek; Joanna Wietrzyk; Katarzyna Kempińska; Maria Jastrzębska; Joachim Kusz; Maria Nowak
Journal:  Molecules       Date:  2013-04-17       Impact factor: 4.411

8.  Synthesis and Pharmacological Effects of Diosgenin-Betulinic Acid Conjugates.

Authors:  Zülal Özdemir; Michaela Rybková; Martin Vlk; David Šaman; Lucie Rárová; Zdeněk Wimmer
Journal:  Molecules       Date:  2020-08-03       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.